AbstractDiscrepancies in morbidity and local recurrence rates in published clinical trials of pelvic XRT for colorectal cancer are caused by a variety of complex factors. It is, however, clear that XRT is able to cure early rectal carcinomas and is particularly useful in alleviating the symptoms of advanced or recurrent disease. The selection of appropriate cases for combinations of XRT and surgery can be made on the basis of digital examination under anaesthetic. One aim of these combinations is to reduce the number of patients with mobile tumours of the lower two-thirds of the rectum who require a permanent colostomy. In the absence of effective chemotherapy for metastatic disease, liver XRT may have a place in controlling the growth rate of occult liver metastases in selected patients.
CitationThe value of radiotherapy for rectal cancer. 1989, 3 (3):647-69 Baillieres Clin Gastroenterol
JournalBaillière's Clinical Gastroenterology
- Adjuvant radiation therapy for colorectal cancer.
- Authors: Cummings BJ
- Issue date: 1992 Sep 1
- [Colorectal cancer: what should be the management of primary tumour?].
- Authors: Lelong B, Moutardier V, Delpero JR
- Issue date: 2004 Jan 31
- Intraoperative pelvic brachytherapy for treatment of locally advanced or recurrent colorectal cancer.
- Authors: Turley RS, Czito BG, Haney JC, Tyler DS, Mantyh CR, Migaly J
- Issue date: 2013 Feb
- [Therapy of advanced colorectal cancer].
- Authors: Schalhorn A
- Issue date: 1991 Mar 20
- [Colorectal cancer].
- Authors: Oya M, Sameshima S, Tagaya N, Takeshita E, Koketsu S, Sugamata Y, Yoshiba H, Ueno M, Fujimoto Y, Suenaga M
- Issue date: 2011 Aug